• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年甲状腺微小乳头状癌的临床病理特征及预后因素

Clinical-pathological Characteristics and Prognostic Factors for Papillary Thyroid Microcarcinoma in the Elderly.

作者信息

Tang Jing, Liu Hans B, Yu Lujiao, Meng Xin, Leng Sean X, Zhang Haiyan

机构信息

Department of Geriatrics, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, P.R. China.

Department of Geriatrics, The First People's Hospital of Jingmen, Jingmen, Hubei, 448000, P.R. China.

出版信息

J Cancer. 2018 Jan 1;9(2):256-262. doi: 10.7150/jca.22700. eCollection 2018.

DOI:10.7150/jca.22700
PMID:29344271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5771332/
Abstract

The incidence of papillary thyroid microcarcinoma (PTMC) has increased dramatically over the past three decades worldwide. The annual rate of increase in the elderly (≥65) PTMC patients is 1.4 times higher than that in the adult (<65) PTMC patients. The aim of the present study is to identify the clinical-pathological characteristics and prognostic factors in the elderly PTMC patients. The source population is PTMC patients whose information is available in the Surveillance, Epidemiology and End Results (SEER) database (2004-2013). We analyzed specific selected clinical-pathological parameters and prognostic factors for the PTMC patients who were aged 65 or above (N=4812). Within the elderly group, the male patients, in comparison to the females, had a higher percentage of lymph-node metastases (5.29% vs. 12.27%, < 0.001), distant metastasis (0.27% vs. 1.07%, < 0.001), and stage III-IV tumors (9.19% vs. 15.85%, < 0.001). Moreover, the elderly patients had a lower median cause-specific survival (CSS) compared with the adult patients ( < 0.001). Stage III-IV disease (hazard ratio (HR): 8.064, < 0.001) was a strong risk factor for PTMC CSS. Being female (HR: 0.440, = 0.011), total thyroidectomy (HR: 0.057, = 0.001), and lobectomy (HR: 0.058, < 0.001) were all strong protectors of PTMC CSS. Thyroidectomy improved CSS of the elderly PTMC patients. Compared with thyroid lobectomy, total thyroidectomy did not increase CSS for the elderly PTMC patients. The elderly PTMC patients who received radio therapy did not experience an increase in CSS.

摘要

在过去三十年里,全球甲状腺微小乳头状癌(PTMC)的发病率急剧上升。老年(≥65岁)PTMC患者的年增长率比成年(<65岁)PTMC患者高1.4倍。本研究的目的是确定老年PTMC患者的临床病理特征和预后因素。源人群为监测、流行病学和最终结果(SEER)数据库(2004 - 2013年)中可获取信息的PTMC患者。我们分析了年龄在65岁及以上的PTMC患者(N = 4812)特定选择的临床病理参数和预后因素。在老年组中,男性患者与女性患者相比,有更高比例的淋巴结转移(5.29%对12.27%,<0.001)、远处转移(0.27%对1.07%,<0.001)以及III - IV期肿瘤(9.19%对15.85%,<0.001)。此外,老年患者的中位特定病因生存率(CSS)低于成年患者(<0.001)。III - IV期疾病(风险比(HR):8.064,<0.001)是PTMC患者CSS的一个强风险因素。女性(HR:0.440,=0.011)、甲状腺全切术(HR:0.057,=0.001)和甲状腺叶切除术(HR:0.058,<0.001)都是PTMC患者CSS的强保护因素。甲状腺切除术改善了老年PTMC患者的CSS。与甲状腺叶切除术相比,甲状腺全切术并未增加老年PTMC患者的CSS。接受放疗的老年PTMC患者的CSS并未增加。

相似文献

1
Clinical-pathological Characteristics and Prognostic Factors for Papillary Thyroid Microcarcinoma in the Elderly.老年甲状腺微小乳头状癌的临床病理特征及预后因素
J Cancer. 2018 Jan 1;9(2):256-262. doi: 10.7150/jca.22700. eCollection 2018.
2
Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.比较乳头状甲状腺癌和微癌的临床病理特征和预后:基于人群的倾向评分匹配分析。
Front Endocrinol (Lausanne). 2022 Aug 5;13:944758. doi: 10.3389/fendo.2022.944758. eCollection 2022.
3
[Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].[甲状腺乳头状微小癌。587例患者的长期预后与已发表数据的比较]
Minerva Chir. 2007 Oct;62(5):315-25.
4
A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.在患有甲状腺微小乳头状癌的患者中,行肺叶切除术与甲状腺全切除术的比较:一项回顾性个体风险因素匹配队列研究。
Eur J Endocrinol. 2017 Apr;176(4):371-378. doi: 10.1530/EJE-16-0845. Epub 2017 Jan 15.
5
Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?甲状腺微小乳头状癌行甲状腺腺叶切除术:是否需要行甲状腺全切除术?
Int J Surg. 2017 May;41 Suppl 1:S34-S39. doi: 10.1016/j.ijsu.2017.02.012.
6
Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?所有甲状腺微小乳头状癌都应考虑行中央区淋巴结清扫吗?
Asian J Surg. 2016 Oct;39(4):197-201. doi: 10.1016/j.asjsur.2015.02.006. Epub 2015 Apr 22.
7
Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.339例甲状腺乳头状微小癌患者中意外发现及非意外发现病例的临床和病理特征
Head Neck. 2014 Apr;36(4):564-70. doi: 10.1002/hed.23333. Epub 2013 Jun 18.
8
Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.确定甲状腺微小乳头状癌患者甲状腺切除术和淋巴结清扫术的最佳范围。
Front Endocrinol (Lausanne). 2019 Jun 19;10:363. doi: 10.3389/fendo.2019.00363. eCollection 2019.
9
Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.利用超声引导下细针穿刺活检样本的蛋白质组学分析破译甲状腺乳头状微癌淋巴结转移的新型生物标志物。
J Proteomics. 2019 Jul 30;204:103414. doi: 10.1016/j.jprot.2019.103414. Epub 2019 Jun 10.
10
Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?哪些甲状腺微小乳头状癌应被视为“真正的癌症”,哪些应被视为“癌前病变”?
World J Surg Oncol. 2019 May 31;17(1):91. doi: 10.1186/s12957-019-1638-0.

引用本文的文献

1
Effects of fibroblast growth factor 21 serum level on clinicopathological findings in papillary thyroid carcinoma.成纤维细胞生长因子21血清水平对甲状腺乳头状癌临床病理特征的影响。
Caspian J Intern Med. 2024 Oct 19;16(1):58-65. doi: 10.22088/cjim.16.1.58. eCollection 2025 Winter.
2
Geriatric Importance of Histopathological Parameters Evaluated in Thyroidectomy Specimens: A Single Center Retrospective Analysis.甲状腺切除标本中评估的组织病理学参数的老年医学意义:单中心回顾性分析
J Pers Med. 2024 Jan 15;14(1):95. doi: 10.3390/jpm14010095.
3
A systematic review and meta-analysis comparing tumor progression and complications between radiofrequency ablation and thyroidectomy for papillary thyroid carcinoma.一项比较射频消融术与甲状腺切除术治疗甲状腺乳头状癌的肿瘤进展和并发症的系统评价与荟萃分析。
Front Oncol. 2022 Nov 30;12:994728. doi: 10.3389/fonc.2022.994728. eCollection 2022.
4
Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma.甲状腺微小乳头状癌中央区淋巴结转移的预测因素
World J Clin Cases. 2020 Apr 26;8(8):1350-1360. doi: 10.12998/wjcc.v8.i8.1350.
5
Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly.老年甲状腺微小乳头状癌的临床病理特征及复发风险
Cancer Manag Res. 2019 Mar 25;11:2371-2377. doi: 10.2147/CMAR.S198451. eCollection 2019.

本文引用的文献

1
Observation versus thyroidectomy for papillary thyroid microcarcinoma in the elderly.老年甲状腺乳头状微小癌的观察与甲状腺切除术对比研究
J Laryngol Otol. 2017 Feb;131(2):173-176. doi: 10.1017/S0022215116009762. Epub 2016 Dec 23.
2
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.甲状腺微小乳头状癌手术的临床病理特征、预后及其与BRAFV600E突变状态和血管生成因子表达的关系
PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.
3
Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.甲状腺微小乳头状癌淋巴结转移的风险预测与临床模型构建
Onco Targets Ther. 2016 Aug 24;9:5307-16. doi: 10.2147/OTT.S107913. eCollection 2016.
4
A Risk Model for Predicting Central Lymph Node Metastasis of Papillary Thyroid Microcarcinoma Including Conventional Ultrasound and Acoustic Radiation Force Impulse Elastography.一种用于预测甲状腺微小乳头状癌中央区淋巴结转移的风险模型,包括传统超声和声学辐射力脉冲弹性成像。
Medicine (Baltimore). 2016 Jan;95(3):e2558. doi: 10.1097/MD.0000000000002558.
5
Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database.美国非洲裔、白种人和华裔结直肠癌患者生存及临床病理特征的比较:监测、流行病学和最终结果(SEER)数据库的结果
Oncotarget. 2015 Oct 20;6(32):33935-43. doi: 10.18632/oncotarget.5223.
6
Papillary thyroid microcarcinoma: an over-treated malignancy?甲状腺微小乳头状癌:一种过度治疗的恶性肿瘤?
World J Surg. 2014 Sep;38(9):2297-303. doi: 10.1007/s00268-014-2602-3.
7
An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging.甲状腺癌发病率呈指数级增长:CT 成像的趋势和影响。
AJNR Am J Neuroradiol. 2014 Apr;35(4):778-83. doi: 10.3174/ajnr.A3743. Epub 2013 Oct 10.
8
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.患者年龄与观察中的甲状腺微小乳头状癌的进展显著相关。
Thyroid. 2014 Jan;24(1):27-34. doi: 10.1089/thy.2013.0367. Epub 2013 Nov 14.
9
Controversies in primary treatment of low-risk papillary thyroid cancer.低危型甲状腺乳头状癌的初级治疗争议。
Lancet. 2013 Mar 23;381(9871):1046-57. doi: 10.1016/S0140-6736(12)62205-3. Epub 2013 Mar 22.
10
Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.侵袭性甲状腺微小乳头状癌与甲状腺外侵犯和淋巴结转移相关:一项基于人群的分析。
Thyroid. 2013 Oct;23(10):1305-11. doi: 10.1089/thy.2012.0563. Epub 2013 Sep 14.